Young Oh

Young (Danny) Oh serves as the Executive Director and Gastroenterology Clinical Development Program Lead at Bristol Myers Squibb, overseeing clinical development for programs involving ozanimod, deucravacitinib, cendakimab, and HSP47. Previous experience includes an Executive Director role at Boehringer Ingelheim, leading medical affairs and clinical development in gastroenterology, and a Global Development Lead position at Genentech, focusing on hepatitis B. Danny Oh's extensive background encompasses various leadership roles in immunology, infectious diseases, and ophthalmology, along with academic appointments at the Medical College of Wisconsin and the University of Pennsylvania School of Medicine. Educational credentials include a Doctor of Medicine from The University of Texas Southwestern Medical School, a Master of Science in Clinical and Translational Science from the Medical College of Wisconsin, and a Bachelor of Science in Chemical Engineering from the University of Michigan.